| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/19/2004 | CN1498083A Health foods containing natto kinase and fermented milk products |
| 05/19/2004 | CN1150314C Immunity enhancing lactic acid bacteria |
| 05/19/2004 | CN1150024C Dankang medicine for curing cholecystopathy |
| 05/19/2004 | CN1150023C Medicine for curing male infertility and female sterility |
| 05/19/2004 | CN1150021C Capsule for treating peptic ulcer and its preparation method |
| 05/19/2004 | CN1150019C Medicine for treating hecrosis of femoral head |
| 05/19/2004 | CN1150017C Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 05/19/2004 | CN1150016C Medicine for treating fever caused by lupus erythematosus immunological disease |
| 05/19/2004 | CN1150015C Medicine for treating leucocytopenia caused by lupus erythematosus |
| 05/19/2004 | CN1150014C Medicine for treating lupus erythematosus |
| 05/19/2004 | CN1150012C Chinese patent medicine for treating hyperosteogeny |
| 05/19/2004 | CN1150011C 'Qingzhang Mingmu' pills for clearing eyes and its preparation method |
| 05/19/2004 | CN1150009C Traditional Chinese medicine for female acyesis |
| 05/19/2004 | CN1150007C Externally applied Chinese medicine for rheumatism and asthma |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/19/2004 | CN1150005C External medicine for treating tinea |
| 05/19/2004 | CN1150004C Low temperature albumin fractionation using sodium caprylates as partitioning agent |
| 05/18/2004 | US6737523 For treatment of various forms of cancer |
| 05/18/2004 | US6737398 Administering tumor necrosis factor-alpha directly to lung tissue |
| 05/18/2004 | US6737270 Co-culture of hepatocytes and nonparenchymal cells on a matrix coated with a promoter of cell adhesion, proliferation or survival, in the presence of growth factors; used to form bio-articial livers for treating hepatic disorder |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737083 Topically applied synthetic ocean water mixture and method of using same |
| 05/18/2004 | US6737074 Cells in a culture medium bind to fibrin microbeads which are biologically active and comprise very crosslinked fibrin(ogen); transplanting; engineering tissue by applying to a prosthesis; separating cells; wound healing agents |
| 05/18/2004 | US6737072 Matrix for tissue engineering formed of a hyaluronic acid ester and hydrolyzed collagen |
| 05/18/2004 | US6737054 Myocardial grafts and cellular compositions useful for same |
| 05/18/2004 | US6737051 Cell composition comprising macrophages and progenitor cells |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/13/2004 | WO2004039967A1 Immortalized natural killer cell line |
| 05/13/2004 | WO2004039393A1 Anti-tumor combinations comprising proteins and chemotherapeutics |
| 05/13/2004 | WO2004039383A1 Remedy for fibromyalgia |
| 05/13/2004 | WO2004039382A1 Enhanced production of clotting factors by cryoprecipitation |
| 05/13/2004 | WO2004039248A2 Repairing or replacing tissues or organs |
| 05/13/2004 | WO2004019960A3 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 05/13/2004 | WO2004015077A3 Compositions and methods for neural differentiation of embryonic stem cells |
| 05/13/2004 | WO2004014302A3 Mechanisms of myoblast transfer in treating heart failure |
| 05/13/2004 | WO2004000415A3 Tissue reconstruction and regeneration |
| 05/13/2004 | WO2003101389A3 Relief of aids symptoms |
| 05/13/2004 | WO2003057892B1 Viruses with enhanced lytic potency |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003006950B1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 05/13/2004 | WO2002096195A8 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 05/13/2004 | WO2002088348A3 Lipid producing cells and uses thereof |
| 05/13/2004 | WO2002034272A3 Methods of improving central nervous system functioning |
| 05/13/2004 | US20040092013 Method of treating alzheimer's disease with cell therapy |
| 05/13/2004 | US20040092012 Process for producing nerve stem cells, motor neurons, and gabaergic neurons from embryonic stem cells |
| 05/13/2004 | US20040092011 Adipocytic differentiated adipose derived adult stem cells and uses thereof |
| 05/13/2004 | US20040092010 Using sonic hedgehog activator to propagate cells from central nervous and treat nervous system and neurodegenerative diseases |
| 05/13/2004 | US20040092000 Process for producing a culture of antrodia camphorata and product obtained thereby |
| 05/13/2004 | US20040091999 Process for producing a culture of antrodia camphorata and product obtained thereby |
| 05/13/2004 | US20040091996 Genetically engineered virus which propagates specifically in tumor cells and codes angiogensis inhibitors; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091936 Library or plurality of human or non-human animal progenitor cells; tissue engineering and gene therapy |
| 05/13/2004 | US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/13/2004 | US20040091463 Sensitization of neoplastic cells to radiation therapy with reovirus |
| 05/13/2004 | US20040091461 Urinary tract tissue graft compositions and methods for producing same |
| 05/13/2004 | US20040091459 Bone graft material incorporating demineralized bone matrix and lipids |
| 05/13/2004 | US20040091458 Method for reducing pain using oncolytic viruses |
| 05/13/2004 | DE10251301A1 Protective, soothing and healing medium locally applicable to the skin is based on ostrich fat |
| 05/12/2004 | EP1418228A1 Macroencapsulated secretory cells |
| 05/12/2004 | EP1417970A2 Anti-allergic, anti-bacteric and anti-redden compound for eyes |
| 05/12/2004 | EP1417969A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application |
| 05/12/2004 | EP1417968A2 Antitumour compositions containing propolis and resveratrol |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417323A2 Humanised baculovirus |
| 05/12/2004 | EP1417300A1 Process for the maturation of dentritic cells and a vaccine |
| 05/12/2004 | EP1416977A2 Device for regeneration of articular cartilage and other tissue |
| 05/12/2004 | EP1416973A2 Modulation of mhc class i antigen presentation |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | EP1416944A1 Composition for treatment of articular cartilage damage |
| 05/12/2004 | EP1416943A1 Tissue implants and methods for making and using same |
| 05/12/2004 | EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1226267B1 Process for producing a product containing antihypertensive tripeptides |
| 05/12/2004 | EP1196030B1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 05/12/2004 | EP1151756A4 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 05/12/2004 | EP1147181B1 Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer |
| 05/12/2004 | EP0862444B1 Treatment of dilated cardiomyopathy by removal of autoantibodies |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0627912B1 Gels for encapsulation of biological materials |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1494914A Prduction method of holothurian oral lozenge |
| 05/12/2004 | CN1149280C Replacement therapy for dental caries |
| 05/12/2004 | CN1149103C Method for reduction of the inrectiouseness of potentially infectious material |
| 05/12/2004 | CN1149099C Capsule for treating cholasma and acne and its preparing process |
| 05/12/2004 | CN1149096C Medicine for treating drug-fast tuberculosis |
| 05/12/2004 | CN1149093C Medicine for treating female acyesis |
| 05/11/2004 | US6734338 Using composition for in vitro and in vivo transfection of vertebrate male germ cells comprising a nucleic acid or transgene and a gene delivery system, and optionally a protective internalizing agent |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734018 Prepartion of soft tissue graft for implantation into a mammals; obtain tissue, expose to enzymes and detergents, wash, recover tissue graft, immerse in storage solution |
| 05/11/2004 | US6734015 Capable of self-renewal and differentiation into neurons, but not into glia, i.e. astrocytes and oligodendrocytes |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734008 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |